Medicinal Products

Dáil Éireann Debate, Tuesday - 7 July 2026

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 7 July 2026

Questions (765)

Ken O'Flynn

Question:

765. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, to clarify whether the figure provided for the number of pharmacy reimbursement claims rejected in each year counts unique claims finally refused or counts error events including claims that were subsequently paid; and the reason the combined total of claims approved and claims rejected exceeds the number of claims submitted in 2022. [51062/26]

Written answers

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer